An MedTech West seminar: New imaging biomarkers of liver and lung function with Paul Hockings
Medical imaging enhances the ability to quantify the impact of drugs on human health compared to ordinary or invasive clinical assessments and can therefore be used to decrease patient numbers and/or duration of exposure in clinical trials and to accelerate drug development.
This presentation will discuss AstraZeneca’s efforts to develop new imaging biomarkers of liver and lung function using a mixture of animal and human imaging studies. Hepatobiliary transporter function is measured with gadoxetate, a clinically approved MR contrast agent, and novel compartmental modelling. Lung function is measured with oxygen-enhanced MRI and an ultra-short echo time MRI technique to show areas of the lung with reduced ventilation.
Presented by Paul Hockings, associate director and lung larget organ expert, Astra Zeneca; adjunct professor, MedTech West and Chalmers, and Daniel Alamidi, PhD student, Radiation Physics, Gothenburg university, based full time at Astra Zeneca in Mölndal.
Date: September 5, 2014
Time: 11:30-12:15 (-13:00 incl lunch)
Room: Kammaren, Blå stråket 5, Sahlgrenska University Hospital
Register by sending an email to firstname.lastname@example.org. A light lunch will be served at the venue to registered participants. Please write “MTW seminar September 5” in the subject line.
Last day for registration is September 2.